1. Home
  2. NSYS vs NXTC Comparison

NSYS vs NXTC Comparison

Compare NSYS & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSYS
  • NXTC
  • Stock Information
  • Founded
  • NSYS 1981
  • NXTC 2015
  • Country
  • NSYS United States
  • NXTC United States
  • Employees
  • NSYS N/A
  • NXTC N/A
  • Industry
  • NSYS Industrial Machinery/Components
  • NXTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NSYS Technology
  • NXTC Health Care
  • Exchange
  • NSYS Nasdaq
  • NXTC Nasdaq
  • Market Cap
  • NSYS 22.3M
  • NXTC 24.6M
  • IPO Year
  • NSYS N/A
  • NXTC 2019
  • Fundamental
  • Price
  • NSYS $7.34
  • NXTC $9.48
  • Analyst Decision
  • NSYS
  • NXTC Strong Buy
  • Analyst Count
  • NSYS 0
  • NXTC 3
  • Target Price
  • NSYS N/A
  • NXTC $23.00
  • AVG Volume (30 Days)
  • NSYS 12.3K
  • NXTC 61.7K
  • Earning Date
  • NSYS 11-13-2025
  • NXTC 11-05-2025
  • Dividend Yield
  • NSYS N/A
  • NXTC N/A
  • EPS Growth
  • NSYS N/A
  • NXTC N/A
  • EPS
  • NSYS N/A
  • NXTC N/A
  • Revenue
  • NSYS $116,672,000.00
  • NXTC N/A
  • Revenue This Year
  • NSYS N/A
  • NXTC N/A
  • Revenue Next Year
  • NSYS N/A
  • NXTC N/A
  • P/E Ratio
  • NSYS N/A
  • NXTC N/A
  • Revenue Growth
  • NSYS N/A
  • NXTC N/A
  • 52 Week Low
  • NSYS $6.50
  • NXTC $2.69
  • 52 Week High
  • NSYS $12.40
  • NXTC $17.18
  • Technical
  • Relative Strength Index (RSI)
  • NSYS 27.90
  • NXTC 51.80
  • Support Level
  • NSYS $6.50
  • NXTC $8.13
  • Resistance Level
  • NSYS $9.22
  • NXTC $10.74
  • Average True Range (ATR)
  • NSYS 0.37
  • NXTC 1.04
  • MACD
  • NSYS -0.26
  • NXTC -0.31
  • Stochastic Oscillator
  • NSYS 23.93
  • NXTC 26.49

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: